Literature DB >> 7182348

Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites.

W H Chen, J S Horoszewicz, S S Leong, T Shimano, R Penetrante, W H Sanders, R Berjian, H O Douglass, E W Martin, T M Chu.   

Abstract

A human pancreatic tumor cell line has been established from the ascites of a patient with histopathologically confirmed adenocarcinoma of the head of the pancreas and maintained for more than 12 months in the laboratory. Epithelioid tumor cell colonies, which resulted from primary tissue cultures of the ascitic cell component, were mechanically isolated by needle micromanipulation. Tumorigenicity was proven in athymic nude mice. Morphologically the pancreatic tumor epithelial cells grew to confluency with moderately tight adhesion to the culture plastic surface and with free-floating cells in the medium. Upon re-establishment of the tumoral xenograft in tissue culture, the epithelial cells retained their original morphology. Histologically the tumor grown in nude mice exhibited prototypic characteristics of the primary adenocarcinoma in the patient, producing abundant mucin and displaying a broad spectrum of glandular differentiation, which ranged from well to poorly differentiated adenocarcinomas with occasionally localized lymphocytic infiltrations. Furthermore, the tumor expressed carcinoembryonic antigen and human pancreas cancer associated antigen. This tumor line, designated AsPC-1, has been cultured for at least 10 passages in vitro and 3 in vivo. It represents a new model for human pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7182348     DOI: 10.1007/bf02796382

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  21 in total

1.  Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas.

Authors:  M Lieber; J Mazzetta; W Nelson-Rees; M Kaplan; G Todaro
Journal:  Int J Cancer       Date:  1975-05-15       Impact factor: 7.396

Review 2.  Updating the epidemiologic data on pancreatic cancer.

Authors:  J W Berg; R R Connelly
Journal:  Semin Oncol       Date:  1979-09       Impact factor: 4.929

3.  The LNCaP cell line--a new model for studies on human prostatic carcinoma.

Authors:  J S Horoszewicz; S S Leong; T M Chu; Z L Wajsman; M Friedman; L Papsidero; U Kim; L S Chai; S Kakati; S K Arya; A A Sandberg
Journal:  Prog Clin Biol Res       Date:  1980

4.  Immunochemical studies on carcinoembryonic antigen-reactive glycoproteins from carcinomas of the colon and breast separated by concanavalin A affinity chromatography.

Authors:  S R Harvey; R N Girotra; T Nemoto; F Ciani; T M Chu
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

5.  Heterotransplantation of human malignant tumors in "nude" thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors.

Authors:  B C Giovanella; J S Stehlin; L J Williams
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

6.  Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma.

Authors:  R T Morgan; L K Woods; G E Moore; L A Quinn; L McGavran; S G Gordon
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

7.  Differential localization of human pancreas cancer-associated antigen and carcinoembryonic antigen in homologous pancreatic tumoral xenograft.

Authors:  M H Tan; T Shimano; T M Chu
Journal:  J Natl Cancer Inst       Date:  1981-09       Impact factor: 13.506

8.  Establishment and characteristics of a human pancreatic cancer cell line (HCG-25).

Authors:  T Akagi; T Kimoto
Journal:  Acta Pathol Jpn       Date:  1977-01

9.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents.

Authors:  V D Courtenay; J Mills
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

10.  Establishment and characterization of primary human pancreatic carcinoma in continuous cell culture and in nude mice.

Authors:  A G Grant; D Duke; J Hermon-Taylor
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

View more
  54 in total

1.  Characterization of mucin glycoprotein-specific translation products from swine and human trachea, pancreas and colon.

Authors:  S Sangadala; P Wallace; J Mendicino
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

2.  Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer.

Authors:  Peter Büchler; Howard A Reber; Mendel M Roth; Mark Shiroishi; Helmut Friess; Oscar J Hines
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

Review 3.  Understanding Disease Biology and Informing the Management of Pancreas Cancer With Preclinical Model Systems.

Authors:  Martin C Whittle; Sunil R Hingorani
Journal:  Cancer J       Date:  2017 Nov/Dec       Impact factor: 3.360

4.  Culture of human main pancreatic duct epithelial cells.

Authors:  D Oda; C E Savard; T D Nguyen; E R Swenson; S P Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

5.  Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism.

Authors:  Aamod S Dekhne; Changwen Ning; Md Junayed Nayeen; Khushbu Shah; Hasini Kalpage; Josephine Frühauf; Adrianne Wallace-Povirk; Carrie O'Connor; Zhanjun Hou; Seongho Kim; Maik Hüttemann; Aleem Gangjee; Larry H Matherly
Journal:  Mol Pharmacol       Date:  2019-11-09       Impact factor: 4.436

6.  Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).

Authors:  Brittany L Carpenter; Min Chen; Teresa Knifley; Kelley A Davis; Susan M W Harrison; Rachel L Stewart; Kathleen L O'Connor
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

7.  A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.

Authors:  Jianliang Zhang; Di-Hua He; Maria Zajac-Kaye; Steven N Hochwald
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  New cell lines of gastric and pancreatic cancer: distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens.

Authors:  M Heike; O Röhrig; H E Gabbert; R Moll; K H Meyer zum Büschenfelde; W G Dippold; A Knuth
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Generation of an in vitro 3D PDAC stroma rich spheroid model.

Authors:  Matthew J Ware; Vazrik Keshishian; Justin J Law; Jason C Ho; Carlos A Favela; Paul Rees; Billie Smith; Sayeeduddin Mohammad; Rosa F Hwang; Kimal Rajapakshe; Cristian Coarfa; Shixia Huang; Dean P Edwards; Stuart J Corr; Biana Godin; Steven A Curley
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

10.  Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy.

Authors:  Tomohiro Shimizu; María P Torres; Subhankar Chakraborty; Joshua J Souchek; Satyanarayana Rachagani; Sukhwinder Kaur; Muzafar Macha; Apar K Ganti; Ralph J Hauke; Surinder K Batra
Journal:  Cancer Lett       Date:  2013-03-21       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.